Coimbra hosts international scientific congress on the use of medical cannabis
The event's primary goal is to discuss the use of medical cannabis in several medical conditions.
English version: Diana Taborda
The international congress MCC, “Medical Cannabis Coimbra - Clearing the smoke...: the importance of the endocannabinoid system in health and disease” will take place on the 9th and 10th of March at Auditorium 2 of the UC Student Hub.
The event, organised by the Centre for Neuroscience and Cell Biology of the University of Coimbra (CNC-UC) and promoted by a team led by researcher Attila Köfalvi, aims to discuss the use of medical cannabis in several medical conditions, namely in the management of chronic pain and in cancer, as well as the legal and regulatory implications of the use of medical cannabis in Portugal.
The congress will have several lectures delivered by renowned experts in the field addressing topics such as the botany of the cannabis plant, its effects on the human body and on the endocannabinoid system - known for regulating a series of physiological functions such as communication between brain cells, appetite, pain, inflammation, metabolism, memory, stress response, mood and quality of sleep.
The scientific meeting has the support of the International Brain Research Organization (IBRO), the Portuguese Society for Neuroscience (SPN) and the University of Coimbra PHD Programme in Experimental Biology and Biomedicine (PDBEB).
More info at: https://mcc.cnc.uc.pt/